Super Gonorrhea

Antibiotic-Resistant Super Gonorrhea (CDC).

"We are currently down to one last recommended and effective class of antibiotics, cephalosporins, to treat this common infection." "Gonorrhea is skilled at outsmarting the...

Is Overuse of Antibiotics on Farms Worsening the Spread of Antibiotic-Resistant Bacteria? (CBSNews)

Public health officials investigating a drug-resistant salmonella outbreak in 2015 still don't know the exact source after a pork-industry lobbying group on behalf of...

Drug Resistance Could Kill 10M People per year by 2050, Experts say (Axios).

Infectious disease experts tell Axios they agree with a dire scenario painted in the UN report posted earlier this week saying that, if nothing changes, antimicrobial...

CDC’s Worst-Case Coronavirus Model: 214 Million Infected, 1.7 Million Dead (Intelligencer)

A recent CDC projection estimated that the U.S. coronavirus epidemic could infect between 160 million and 214 million people over a period of more...
Biotech Stock Review, Exsosomes

Exosomes, Extracellular Vesicles, and the CoronaVirus.

Uploading a Series of Articles on Extracellular Vesicles, Including Potential Effects on the CoronaVirus and ARDS. Article #1: the basics in non-scientific terms from Larry...
Corbus Pharma, Biotech Stock Review

Adding Corbis Pharma (CRBP) $5.55 to Watch List.

Running Clinical Trials Full Steam With $46 Million Banked in Late February. Not thinly, but lightly traded. Ready, locked and loaded. All of the common...
Athersys, Biotech Stock Review

Boo Ya. Brokerage Sets $12 Price Target for Athersys (ATHX) $2.96.

A major Wall Street firm that specializes in Bio and Medtech Companies has a $12 price target out on Athersys from one of its...

Athersys (ATHX) Overview and Due Diligence links (Reddit)

I've (Dalek on Reddit) compiled a list of links that might be useful if you are disorganized like myself. If you are a newcomer...
Biotech Stock Review, Novellus, Citius

Citius (CTXR) and Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19

Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 - Novellus's patented mRNA-based cell-reprogramming...

New Report: Citius (CTXR) Trades 13 Million Shares on CoronaVirus and Candida Auris News.

Announces Mino-lok® Erdicates the Deadly and Untreatable C. Auris Bacteria.Announces License of Treatment for CoronaVirus Respiratory Failure. Read In Between the Lines. If the Mino-Lok®...

Latest article

Perpetua Resources (PPTA) Joins the Billion Dollar Club 

Perpetua Resources (PPTA) Joins the Billion Dollar Club Launching Institutional Gold Analyst and Gold Investor Conference1. Adding Perpetua Resources (PPTA) $13.60 to Watchlist. Antimony Heaven.2....

Blue Ocean Equities Report on Antimony.

Antimony Macro Note: Don’t expect Sb prices to pull back anytime soon! ANTIMONY MACRO NOTE On Gold Investment Conference A simply fantastic report (best in world) though...

Gold Miners Printing Record Margins – Juniors Could 10x From Here | Video

Charles Haggar, Mathieu Boisvert and Michael Gentile Will permitting reform in North America unlock trillions in hidden value? Gold and silver are soaring, but junior...